eISSN: 1896-9151
ISSN: 1734-1922
Archives of Medical Science
Current issue Archive Manuscripts accepted About the journal Special issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors
SCImago Journal & Country Rank
vol. 14
Clinical research

Genotype distribution of hepatitis C virus in 952 cases from 2014 to 2016 in Hunan Province, China

Jian-Hua Lei, Xing Gong, Xin-Qiang Xiao, Zi Chen, Feng Peng

Arch Med Sci 2018; 14, 5: 1055–1060
Online publish date: 2017/10/12
View full text
Get citation
JabRef, Mendeley
Papers, Reference Manager, RefWorks, Zotero
Few large-scale investigations on genotype (GT) distribution of hepatitis C virus (HCV) in Hunan Province, China, are reported.

Material and methods
We recruited all of the 952 patients in the census register of Hunan Province who were first diagnosed with HCV infection in the Second Xiangya Hospital, Central South University in 2014–2016. HCV genotypes were surveyed. The genotype distribution pattern was compared with those of the neighboring regions in China.

Among the 952 patients, genotype 1 (GT1) (69.9%) was the most common HCV genotype, followed by GT6 (19.0%), GT3 (8.4%), and GT2 (2.6%). GT4 and GT5 were not found. One case had mixed infection of GT3 and GT6. Predominance of GT1 HCV was more evident in the patients aged ≥ 40 years than in those aged < 40 years (79.5% vs. 47.9%, 2 = 95.993, p < 0.001). HCV genotype distribution had gender difference (2 = 44.695, p < 0.001), with GT3 and GT6 more prevalent in males than in females (36.2% vs. 18.2%, 2 = 39.088, p < 0.001) while GT1 more prevalent in females than in males (80.1% vs. 60.3%, 2 = 44.276, p < 0.001). Though Hunan Province is located in central China, its HCV genotype priority was similar with the change trend in south and southwest China, while distinguished from those of other regions, in particular from the neighboring central province, Hubei Province.

HCV GT1 was the most predominant HCV genotype in Hunan Province, and GT6 and GT3 accounted for a significant percentage, especially in young patients. The HCV distribution pattern was more similar to those of the regions in south China.


epidemiology, hepatitis C virus, genotype

Thomas DL. Global control of hepatitis C: where challenge meets opportunity. Nat Med 2013; 19: 850-8.
Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology 2013; 57: 1333-42.
Cui Y, Jia J. Update on epidemiology of hepatitis B and C in China. J Gastroenterol Hepatol 2013; 28 (Suppl 1): 7-10.
Chinese Society of Hepatology, Chinese Society of Infectious Diseases. The guideline of prevention and treatment for hepatitis C: a 2015 update. Zhonghua Gan Zang Bing Za Zhi 2015; 23: 906-23.
Omata M, Kanda T, Wei L, et al. APASL consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testing. Hepatol Int 2016; 10: 681-701.
Gower E, Estes C, Blach S, Razavi-Shearer K, Razavi H. Global epidemiology and genotype distribution of the hepatitis C virus infection. J Hepatol 2014; 61 (1 Suppl): S45-57.
Zhang Y, Chen LM, He M. Hepatitis C virus in mainland China with an emphasis on genotype and subtype distribution. Virol J 2017; 14: 41.
Omata M, Kanda T, Wei L, et al. APASL consensus statements and recommendation on treatment of hepatitis C. Hepatol Int 2016; 10: 702-26.
AASLD/IDSA HCV Guidance Panel. Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus. Hepatology 2015; 62: 932-54.
European Association for the Study of the Liver. EASL Recommendations on Treatment of Hepatitis C 2016. J Hepatol 2017; 66: 153-94.
Rao H, Wei L, Lopez-Talavera JC, et al. Distribution and clinical correlates of viral and host genotypes in Chinese patients with chronic hepatitis C virus infection. J Gastroenterol Hepatol 2014; 29: 545-53.
Lu L, Wang M, Xia W, et al. Migration patterns of hepatitis C virus in China characterized for five major subtypes based on samples from 411 volunteer blood donors from 17 provinces and municipalities. J Virol 2014; 88: 7120-9.
Rong X, Xu R, Xiong H, et al. Increased prevalence of hepatitis C virus subtype 6a in China: a comparison between 2004-2007 and 2008-2011. Arch Virol 2014; 159: 3231-7.
Yan Z, Fan K, Wang Y, Fan Y, Tan Z, Deng G. Changing pattern of clinical epidemiology on hepatitis C virus infection in Southwest China. Hepat Mon 2012; 12: 196-204.
Nakatani SM, Santos CA, Riediger IN, et al. Development of hepatitis C virus genotyping by real-time PCR based on the NS5B region. PLoS One 2010; 5: e10150.
Rolfe KJ, Wreghitt TG, Alexander GJ, Curran MD. A real-time Taqman method for hepatitis C virus genotyping and methods for further subtyping of isolates. Methods Mol Biol 2009; 510: 55-71.
Prajsner A, Chudek J, Szybalska A, Piotrowicz K, Zejda J, Więcek A; PolSenior Study Group. Socioeconomic determinants of prostate-specific antigen testing and estimation of the prevalence of undiagnosed prostate cancer in an elderly Polish population based on the PolSenior study. Arch Med Sci 2016; 12: 1028-35.
Peng J, Lu Y, Liu W, et al. Genotype distribution and molecular epidemiology of hepatitis C virus in Hubei, Central China. PLoS One 2015; 10: e0137059.
Ju W, Yang S, Feng S, et al. Hepatitis C virus genotype and subtype distribution in Chinese chronic hepatitis C patients: nationwide spread of HCV genotypes 3 and 6. Virol J 2015; 12: 109.
Zhang Z, Yao Y, Wu W, et al. Hepatitis C virus genotype diversity among intravenous drug users in Yunnan Province, Southwestern China. PLoS One 2013; 8: e82598.
Yin W, Huang C, Qiu F, et al. Risk factors of hepatitis C virus transmission and genotype distribution in former blood donors from Chinese rural area. BMC Public Health 2015; 15: 184.
Pajak A, Szafraniec K, Polak M, et al. Prevalence of familial hypercholesterolemia: a meta-analysis of six large, observational, population-based studies in Poland. Arch Med Sci 2016; 12: 687-96.
Salemovic D, Pesic-Pavlovic I, Jevtovic D, et al. Intravenous drug use – an independent predictor for HCV genotypes 3 and 4 infection among HIV/HCV co-infected patients. Arch Med Sci 2017; 13: 652-8.
Jiao Y, Zhang X, Wang C, et al. Hepatitis C virus subtype and evolution characteristic among drug users, men who have sex with men, and the general population in Beijing, China. Medicine (Baltimore) 2016; 95: e2688.
Lu L, Tong W, Gu L, et al. The current hepatitis C virus prevalence in China may have resulted mainly from an officially encouraged plasma campaign in the 1990s: a coalescence inference with genetic sequences. J Virol 2013; 87: 12041-50.
Wang CB, Cheng ZX, Chen JJ, et al. Epidemiological characteristics and risk factors of hepatitis C virus geno­type 1 infection: a national epidemiological survey of Chinese Han population. Eur Rev Med Pharmacol Sci 2016; 20: 1052-6.
Quick links
© 2019 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe